Found: 49
Select item for more details and to access through your institution.
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.
- Published in:
- 2015
- By:
- Publication type:
- journal article
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 8, p. 792, doi. 10.3390/jpm11080792
- By:
- Publication type:
- Article
A Case of Primary Mediastinal B-Cell Lymphoma Diagnosed during Cesarean Section: A Rare Presentation.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 3, p. 1
- By:
- Publication type:
- Article
Delphi consensus for the third-line treatment of metastatic colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 6, p. 1429, doi. 10.1007/s12094-023-03369-1
- By:
- Publication type:
- Article
Recommendations for the optimal management of peritoneal metastases in patients with colorectal cancer: a TTD and GECOP-SEOQ expert consensus statement.
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 12, p. 3378, doi. 10.1007/s12094-023-03204-7
- By:
- Publication type:
- Article
SEOM-GEMCAD-TTD clinical guidelines for the systemic treatment of metastatic colorectal cancer (2022).
- Published in:
- Clinical & Translational Oncology, 2023, v. 25, n. 9, p. 2718, doi. 10.1007/s12094-023-03199-1
- By:
- Publication type:
- Article
Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 11, p. 2107, doi. 10.1007/s12094-022-02873-0
- By:
- Publication type:
- Article
Guidelines for biomarker testing in colorectal carcinoma (CRC): a national consensus of the Spanish Society of Pathology (SEAP) and the Spanish Society of Medical Oncology (SEOM).
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 10, p. 726, doi. 10.1007/s12094-012-0856-5
- By:
- Publication type:
- Article
A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 5, p. 323, doi. 10.1007/s12094-012-0803-5
- By:
- Publication type:
- Article
Recommendations and expert opinion on the treatment of locally advanced rectal cancer in Spain.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 12, p. 862, doi. 10.1007/s12094-011-0747-1
- By:
- Publication type:
- Article
Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.
- Published in:
- Clinical & Translational Oncology, 2011, v. 13, n. 9, p. 636, doi. 10.1007/s12094-011-0709-7
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of advanced colorectal cancer.
- Published in:
- Clinical & Translational Oncology, 2010, v. 12, n. 11, p. 729, doi. 10.1007/s12094-010-0587-4
- By:
- Publication type:
- Article
Acquired ichthyosis as a paraneoplastic syndrome in Hodgkin’s disease.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 8, p. 552, doi. 10.1007/s12094-009-0402-2
- By:
- Publication type:
- Article
Adjuvant chemotherapy for stages II, III and IV of colon cancer.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 8, p. 526, doi. 10.1007/s12094-009-0397-8
- By:
- Publication type:
- Article
Colorectal cancer prevention.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Primary ovarian Burkitt lymphoma.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 10, p. 673, doi. 10.1007/s12094-008-0270-1
- By:
- Publication type:
- Article
First-line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 3, p. 182, doi. 10.1007/s12094-008-0178-9
- By:
- Publication type:
- Article
Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Oral drugs in the treatment of metastatic colorectal cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211009001
- By:
- Publication type:
- Article
Panitumumab Use in Metastatic Colorectal Cancer and Patterns of KRAS Testing: Results from a Europe-Wide Physician Survey and Medical Records Review.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0140717
- By:
- Publication type:
- Article
Bevacizumab in Combination with Capecitabine plus Irinotecan as First-Line Therapy in Metastatic Colorectal Cancer: A Pooled Analysis of 2 Phase II Trials.
- Published in:
- Oncology Research & Treatment, 2013, v. 36, n. 6, p. 363, doi. 10.1159/000351240
- By:
- Publication type:
- Article
Early Clinical Experience with Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: The ROS Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4514, doi. 10.3390/cancers13184514
- By:
- Publication type:
- Article
Biomarkers Associated with Regorafenib First-Line Treatment Benefits in Metastatic Colorectal Cancer Patients: REFRAME Molecular Study.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1710, doi. 10.3390/cancers13071710
- By:
- Publication type:
- Article
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET Study.
- Published in:
- Cancers, 2020, v. 12, n. 8, p. 2259, doi. 10.3390/cancers12082259
- By:
- Publication type:
- Article
Safety and Effectiveness of Aflibercept + Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) for the Treatment of Patients with Metastatic Colorectal Cancer (mCRC) in Current Clinical Practice: OZONE Study.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 657, doi. 10.3390/cancers12030657
- By:
- Publication type:
- Article
Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5382, doi. 10.1002/cam4.1703
- By:
- Publication type:
- Article
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study.
- Published in:
- Clinical & Translational Oncology, 2024, v. 26, n. 10, p. 2640, doi. 10.1007/s12094-024-03487-4
- By:
- Publication type:
- Article
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
- Published in:
- Molecular Diagnosis & Therapy, 2015, v. 19, n. 6, p. 397, doi. 10.1007/s40291-015-0165-0
- By:
- Publication type:
- Article
Relationships Between Kohne Category/Baseline Tumor Load and Early Tumor Shrinkage, Depth of Response, and Outcomes in Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2021, v. 20, n. 4, p. 305, doi. 10.1016/j.clcc.2021.05.007
- By:
- Publication type:
- Article
Current Options for Third-line and Beyond Treatment of Metastatic Colorectal Cancer. Spanish TTD Group Expert Opinion.
- Published in:
- Clinical Colorectal Cancer, 2020, v. 19, n. 3, p. 165, doi. 10.1016/j.clcc.2020.04.003
- By:
- Publication type:
- Article
A Randomized Phase II Study of Axitinib as Maintenance Therapy After First-line Treatment for Metastatic Colorectal Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Erratum to: Differential toxicity biomarkers for irinotecan- and oxaliplatin- containing chemotherapy in colorectal cancer.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Differential toxicity biomarkers for irinotecan- and oxaliplatin-containing chemotherapy in colorectal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1463, doi. 10.1007/s00280-013-2145-6
- By:
- Publication type:
- Article
Description of the genetic variants identified in a cohort of patients diagnosed with localized anal squamous cell carcinoma and treated with panitumumab.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-86966-w
- By:
- Publication type:
- Article
Indocyanine green clearance test as a predictor of chemotherapy liver toxicity and post-operative complications in patients with colorectal liver metastases.
- Published in:
- Cirugía y Cirujanos, 2022, v. 90, n. 3, p. 310, doi. 10.24875/CIRU.21000313
- By:
- Publication type:
- Article
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
An international comparative analysis and roadmap to sustainable biosimilar markets.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1188368
- By:
- Publication type:
- Article
Correction to: A Phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II Study Evaluating Combined Neoadjuvant Cetuximab and Chemotherapy Followed by Chemoradiotherapy and Concomitant Cetuximab in Locoregional Oesophageal Cancer Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Regorafenib in Advanced Colorectal Cancer.
- Published in:
- Cancer & Chemotherapy Reviews, 2017, v. 12, n. 1, p. 3
- By:
- Publication type:
- Article
The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
- Published in:
- Oncologist, 2020, v. 25, n. 3, p. e451, doi. 10.1634/theoncologist.2019-0291
- By:
- Publication type:
- Article
Single‐Agent Regorafenib in Metastatic Colorectal Cancer Patients with Any RAS or BRAF Mutation Previously Treated with FOLFOXIRI plus Bevacizumab (PREVIUM Trial).
- Published in:
- Oncologist, 2018, v. 23, n. 11, p. 1271, doi. 10.1634/theoncologist.2018-0316
- By:
- Publication type:
- Article
Differences in the Therapeutic Approach to Colorectal Cancer in Young and Elderly Patients.
- Published in:
- Oncologist, 2012, v. 17, n. 10, p. 1277, doi. 10.1634/theoncologist.2012-0060
- By:
- Publication type:
- Article
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis.
- Published in:
- Drugs & Aging, 2021, v. 38, n. 3, p. 219, doi. 10.1007/s40266-021-00834-w
- By:
- Publication type:
- Article
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1512-6
- By:
- Publication type:
- Article
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 495, doi. 10.1186/s12885-015-1512-6
- By:
- Publication type:
- Article
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
- Published in:
- PLoS ONE, 2017, v. 12, n. 10, p. 1, doi. 10.1371/journal.pone.0175484
- By:
- Publication type:
- Article